We all deserve long and healthy lives and innovation in pharmaceuticals is making that a reality. Whether it’s through developing novel treatments for cancers or combatting rare immune diseases, Pharma Breakthrough means better health for all.
Our Pharma Breakthrough fund brings together companies undertaking vital research into treating rare diseases, providing medical breakthroughs in areas where there was previously no satisfactory treatment available.
There are an estimated 6,000-8,000 rare disease affecting 400m people globally. Only 10% of these disease are currently treatable.
Here are some of the companies in the fund operating on the cutting edge of medicine and pharmaceuticals to combat rare diseases
Holdings data taken from fundcentres.lgim.com, rizeetf.com and ishares.com in July 2022. Both the holdings and the number of holdings in any fund can change from time to time.